Market Tracker

05/22 5:16pm ET

Aveo Pharmaceuticals Inc (NASDAQ:AVEO)

2.31
Delayed Data
As of May 22
 +0.08 / +3.59%
Today’s Change
0.61
Today|||52-Week Range
3.50
+174.93%
Year-to-Date

Today’s Trading

Previous close2.23
Today’s open2.40
Day’s range2.15 - 2.75
Volume19,939,711
Average volume (3 months)3,284,480
Market cap$127.2M
Dividend yield--
Data as of 3:59pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)+51.90%
Earnings growth (this year)+20.46%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,301.62%
P/E ratioNM
Price/Sales2.42
Price/Book5.86

Competitors

 Today’s
change
Today’s
% change
NERVMinerva Neuroscience...+0.06+1.19%
RNNRexahn Pharmaceutica...-0.03-4.00%
LPCNLipocine Inc0.000.00%
--United Gene High-Tec...+0.01+14.29%
Data as of 4:02pm ET, 05/22/2015

Financials

Next reporting dateJuly 30, 2015
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$18.1M
Annual profit (last year)-$52.7M
Net profit margin-291.01%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael P. Bailey
Chief Financial Officer
Keith S. Ehrlich
Corporate headquarters
Cambridge, Massachusetts

Forecasts